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The Effects of Estrogen and Arousal on Latent Inhibition
Michael Herron; Megan Raddatz; Dr. Mona Buhusi
Introduction

Results and Conclusion

The behaviors of humans and animals are dependent on
neurotransmitters and hormones that affect attention,
alertness, and associative learning. These include the
hormone estrogen (which plays an interesting role in
cognition
and
attentional
processes)
and
the
neurotransmitter orexin (involved in wakefulness, arousal and
goal-directed behaviors). Here we evaluated the roles of
orexin receptors and estrogen in Latent Inhibition (LI), a
measure of attention and associative learning. Latent
inhibition is a behavioral phenomenon in which an organism’s
ability to associate new meaning to a familiar previously
inconsequential (pre-exposed) stimulus is reduced when
compared to associating meaning to a novel stimulus (non
pre-exposed) in a classical conditioning paradigm. We
hypothesize that orexin and estrogen have synergistic effects
on latent inhibition (LI).

The average time spent freezing during the NPE and PE stimuli
during the test session in animals receiving placebo treatment is
shown in Figure 1. A two-way ANOVA indicates a main effect of
group (F(1, 17) = 4.584, p < 0.05, ηp2 = 0.215)). Under placebo,
both KO and WT animals in the NPE condition showed elevated
freezing times as compared to PE condition. Overall, the results
trend towards a display of LI in both the KO and WT animals
under placebo treatment.
The average time spent freezing during the NPE and PE stimuli
during the test session in KO animals receiving placebo or
estrogen is shown in Figure 2. A separate two-way ANOVA did
not indicate any main effect of treatment (F(1, 14) = 0.064, p >
0.05) or group (F(1, 14) = 1.822, p > 0.05). However, as seen in
Figure 1, the KO under placebo that were not preexposed froze
slightly more than those who were pre-exposed to the
stimuli. While this is not statistically significant, the result trend
toward a display of LI in KO receiving placebo but not in KO
animals receiving estrogen. While the results that were obtained
are of great interest, there exists a necessity to further clarify
the roles that orexin and estrogen play in a latent inhibition
paradigm.

Figure 1

Methods
Subjects
• Female mice, aged 3-4 months, n = 33
• All mice underwent ovariectomy surgery
Experimental Design
• Alterations to the experimental subjects included condition
(non-pre-exposed and pre-exposed), genotype (wild-type vs.
orexin receptor knock-out), and treatment (estrogen vs.
placebo).
Latent Inhibition Paradigm
• In a 5-phase experiment, about half the mice were preexposed to a stimulus and then conditioned with a foot
shock, while the others did not receive pre-exposure.
• Freezing time was then manually recorded upon subsequent
exposure to the stimulus as a measure of LI.
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